Clinical Trial: A Phase II Study of QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07377773) titled 'A Phase II Study of QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis' on Jan. 22.

Brief Summary: The objective of this randomized, double-blind, placebo-controlled phase II clinical trial is to investigate the safety and efficacy of QLS12010 in subjects with moderate-to-severe rheumatoid arthritis.The main questions it aims to answer are:

* Efficacy and safety of QLS12010 in participants with rheumatoid arthritis.

Participants will be randomly allocated to four treatment groups at a 1:1:1:1 ratio to compare the efficacy and safety of different dosages of QLS12010 Capsules against the placebo.

Study Start Date...